IL33 and chronic obstructive pulmonary disease: In summary, our analysis in human COPD illuminates a role for nSMase2 and exosome pathways in the mechanism of IL-33 airway secretion, supported by amelioration of type 2 inflammation with pharmacological blockade of nSMase2 in vivo.